{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:43:03Z","timestamp":1793133783864,"version":"4.5.0"},"reference-count":27,"publisher":"Impact Journals, LLC","issue":"57","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,11,14]]},"DOI":"10.18632\/oncotarget.18890","type":"journal-article","created":{"date-parts":[[2017,6,30]],"date-time":"2017-06-30T15:00:19Z","timestamp":1498834819000},"page":"96903-96912","source":"Crossref","is-referenced-by-count":16,"title":["Posttransplant lymphoproliferative disorders in kidney transplant recipients: a retrospective cohort analysis over two decades in Hong Kong"],"prefix":"10.18632","volume":"8","author":[{"given":"Chi Yuen","family":"Cheung","sequence":"first","affiliation":[{"name":"Renal Unit, Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie Kam Man","family":"Ma","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Foon","family":"Chau","sequence":"additional","affiliation":[{"name":"Renal Unit, Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai Leung","family":"Chak","sequence":"additional","affiliation":[{"name":"Renal Unit, Department of Medicine, Queen Elizabeth Hospital, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney Chi Wai","family":"Tang","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong SAR, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,6,30]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Jaffe","year":"2011","journal-title":"Blood"},{"key":"2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Moulin","year":"2012","journal-title":"Am J Transplant"},{"key":"3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/TP.0000000000001201","article-title":"Posttransplant lymphoproliferative disorders in irish renal transplant recipients: insights from a national observational study","volume":"101","author":"Deady","year":"2017","journal-title":"Transplantation"},{"key":"4","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1111\/j.1600-6143.2012.04209.x","article-title":"Malignancies after kidney transplantation: Hong Kong renal registry","volume":"12","author":"Chau","year":"2012","journal-title":"Am J Transplant"},{"key":"5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Granath","year":"2003","journal-title":"Br J Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/j.1600-6143.2007.01736.x","article-title":"Cancer incidence among Canadian kidney transplant recipients","volume":"7","author":"Mao","year":"2007","journal-title":"Am J Transplant"},{"key":"7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.TP.0000165098.49658.F3","article-title":"Lymphoproliferative disease after renal transplantation in Australia and New Zealand","volume":"80","author":"McDonald","year":"2005","journal-title":"Transplantation"},{"key":"8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/1744-9987.12392","article-title":"Post-transplant lymphoproliferative disorder in kidney transplant recipients: a single-center experience in Japan","volume":"20","author":"Tanabe","year":"2016","journal-title":"Ther Apher Dial"},{"key":"9","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1182\/blood-2015-05-615872","article-title":"How I treat posttransplant lymphoproliferative disorders","volume":"126","author":"Gheysens","year":"2015","journal-title":"Blood"},{"key":"10","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1111\/ajt.13324","article-title":"The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorders","volume":"15","author":"Reshef","year":"2015","journal-title":"Am J Transplant"},{"key":"11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era","volume":"28","author":"Winter","year":"2010","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1200\/JCO.2001.19.3.772","article-title":"Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders","volume":"19","author":"Levy","year":"2001","journal-title":"J Clin Oncol"},{"key":"13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"McGregor","year":"2005","journal-title":"Transplantation"},{"key":"14","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/ajt.12196","article-title":"Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders","volume":"13","author":"Tousseyn","year":"2013","journal-title":"Am J Transplant"},{"key":"15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1470-2045(11)70300-X","article-title":"Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial","volume":"13","author":"Lamy","year":"2012","journal-title":"Lancet Oncol"},{"key":"16","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2005.01098.x","article-title":"Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD)","volume":"5","author":"Riess","year":"2005","journal-title":"Am J Transplant"},{"key":"17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1080\/10428190290033341","article-title":"Post-transplantation lymphoproliferative disease in Chinese: the Queen Mary Hospital experience in Hong Kong","volume":"43","author":"Chiu","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"18","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1399-0012.2011.01593.x","article-title":"Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment","volume":"26","author":"Kwong","year":"2012","journal-title":"Clin Transplant"},{"key":"19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1442-2042.2009.02405.x","article-title":"Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years","volume":"17","author":"Okuyama","year":"2010","journal-title":"Int J Urol"},{"key":"20","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/S0140-6736(05)80084-4","article-title":"Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients","volume":"342","author":"Henderson","year":"1993","journal-title":"Lancet"},{"key":"21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/TP.0b013e318276a237","article-title":"Epidemiology of posttransplantation lymphoproliferative disorder in adult renal transplant recipients","volume":"95","author":"Picton","year":"2013","journal-title":"Transplantation"},{"key":"22","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2009-02-202507","article-title":"Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation","volume":"114","author":"Vajdic","year":"2009","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00007890-200210270-00007","article-title":"Lymphomas occurring late after solid-organ transplantation: influence of treatment on the clinical outcome","volume":"74","author":"Barbui","year":"2002","journal-title":"Transplantation"},{"key":"24","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.2013.253","article-title":"Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival","volume":"85","author":"Thaunat","year":"2014","journal-title":"Kidney Int"},{"key":"25","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses","volume":"75","author":"Wasik","year":"2003","journal-title":"Transplantation"},{"key":"26","doi-asserted-by":"crossref","first-page":"7574","DOI":"10.1200\/JCO.2005.01.0934","article-title":"Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders","volume":"23","author":"McGregor","year":"2005","journal-title":"J Clin Oncol"},{"key":"27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/kisup.2015.7","article-title":"Renal registry in Hong Kong-the first 20 years","volume":"5","author":"Li","year":"2015","journal-title":"Kidney Int Suppl"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T14:18:09Z","timestamp":1589206689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.18890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,30]]},"references-count":27,"journal-issue":{"issue":"57","published-print":{"date-parts":[[2017,11,14]]}},"alternative-id":["18890","29228580"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.18890","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,30]]}}}